{"id":1374,"date":"2024-06-12T09:12:13","date_gmt":"2024-06-12T09:12:13","guid":{"rendered":"https:\/\/www.gide-regimbeau-patentlitigation.com\/?p=1374"},"modified":"2024-06-12T09:20:10","modified_gmt":"2024-06-12T09:20:10","slug":"gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co","status":"publish","type":"post","link":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/","title":{"rendered":"Gide x Regimbeau \u2013 Patent litigation : premi\u00e8re audience historique sur le fond devant la division centrale de Paris de la JUB dans l’affaire Meril Italy S.r.l. contre Edwards Lifesciences Corporation"},"content":{"rendered":"\n

La Juridiction unifi\u00e9e du brevet (“JUB”) a gagn\u00e9 son pari !<\/p>\n\n\n\n

Le 7 juin 2024, et seulement dix mois apr\u00e8s la signification de l’action en r\u00e9vocation en ao\u00fbt 2023, la premi\u00e8re audience sur le fond devant la Division Centrale de Paris (“PCD”) de la JUB s’est historiquement d\u00e9roul\u00e9e dans le cadre de l’action en nullit\u00e9 intent\u00e9e par Meril Italy S.r.l., repr\u00e9sent\u00e9e par Gide x Regimbeau – Patent Litigation, contre le brevet EP 3 646 825 (EP 825), un syst\u00e8me comprenant une valve proth\u00e9tique et un cath\u00e9ter de d\u00e9livrance d\u00e9tenu par Edwards Lifesciences Corporation (“Edwards”), une soci\u00e9t\u00e9 am\u00e9ricaine de technologie m\u00e9dicale dont le si\u00e8ge social se situe \u00e0 Irvine en Californie (USA).<\/p>\n\n\n\n

Ouverte au public, l’audience s’est tenue devant la Court d\u00e9sign\u00e9e pour conna\u00eetre de l’affaire, compos\u00e9e de M. Paolo Catallozzi (IT), juge-pr\u00e9sident et juge-rapporteur, Mme Tatyana Zhilova (BG), juge juridiquement qualifi\u00e9e (LQJ), et M. Stefan Wilhelm (DE), juge techniquement qualifi\u00e9 (TQJ), dans la plus grande salle d’audience de la Chambre internationale du Tribunal de commerce de Paris, \u00e0 la demande des repr\u00e9sentants de Meril Italy S. r.l. (Emmanuel Larere, Rapha\u00eblle Dequir\u00e9-Portier de Gide, et Anne Seibel de Regimbeau) (cliquez ICI<\/a> pour lire l’article relatif \u00e0 cet \u00e9v\u00e9nement).<\/p>\n\n\n\n

L’audience portait sur l’action principale en r\u00e9vocation introduite par Meril Italy S.r.l. contre le brevet EP 825 d’Edwards, ainsi que sur la demande reconventionnelle en r\u00e9vocation introduite par Meril Life Sciences Pvt. Ltd. et Meril GmbH contre le m\u00eame brevet dans la proc\u00e9dure en contrefa\u00e7on devant la division locale de Munich (“MLD”) introduite le 2 novembre 2023, apr\u00e8s que la MLD a renvoy\u00e9 ladite demande reconventionnelle devant la PCD et que le juge-rapporteur de la PCD a d\u00e9cid\u00e9, par ordonnance du 24 mai 2024, d’instruire ensemble ces deux affaires.<\/p>\n\n\n\n

L’audience a d\u00e9but\u00e9 \u00e0 9h30 et a dur\u00e9 jusqu’\u00e0 environ 16h, au cours de laquelle une pause d\u00e9jeuner d’une heure a \u00e9t\u00e9 accord\u00e9e.<\/p>\n\n\n

\n
\"\"
De gauche \u00e0 droite : Ludivine Meissirel (Collaboratrice, Gide), Rapha\u00eblle Dequir\u00e9-Portier (repr\u00e9sentant JUB de Meril Italy S.r.l. et associ\u00e9e, Gide), Emmanuel Larere (repr\u00e9sentant JUB de Meril Italy S.r.l. et associ\u00e9, Gide), Luca Chevallier (counsel, Gide), Anne Seibel (repr\u00e9sentant JUB de Meril Italy S.r.l., conseil en propri\u00e9t\u00e9 industrielle et associ\u00e9e, Regimbeau), Jean-Robert Caillon de Lamarck ((repr\u00e9sentant JUB de Meril Italy S.r.l., conseil en propri\u00e9t\u00e9 industrielle et associ\u00e9, Regimbeau), Julien Guesnier (conseil en propri\u00e9t\u00e9 industrielle, Regimbeau), Aur\u00e9lien Grimberg (conseil en propri\u00e9t\u00e9 industrielle, Regimbeau) et Carole-Anne Bauer (Collaboratrice, Gide).<\/em><\/figcaption><\/figure>\n<\/div>\n\n\n

Les repr\u00e9sentants des trois entit\u00e9s Meril, en tant que demandeurs \u00e0 la r\u00e9vocation, ont pris la parole en premier pour pr\u00e9senter leurs arguments sur les sujets suivants (par ordre chronologique) : questions de proc\u00e9dure li\u00e9es \u00e0 la non-admissibilit\u00e9 de la demande d’Edwards visant \u00e0 modifier le brevet EP 825 en application des r\u00e8gles 50\u00a72 et 30\u00a71 des RoP, added matter<\/em>, priorit\u00e9, claim construction, <\/em>nouveaut\u00e9 et activit\u00e9 inventive.<\/p>\n\n\n\n

La disposition et l’\u00e9quipement de la Chambre internationale du Tribunal de commerce de Paris, ainsi que la disponibilit\u00e9 du greffe de la PCD pour superviser l’organisation de l’audience, ont permis \u00e0 toutes les \u00e9quipes de pr\u00e9senter sur plusieurs grands \u00e9crans des figures et images \u00e0 l’appui de leurs plaidoiries de mani\u00e8re tr\u00e8s visible et claire.<\/p>\n\n\n\n

Apr\u00e8s la pause d\u00e9jeuner, chaque partie a pu revenir sur les points soulev\u00e9s par son adversaire et a ensuite r\u00e9pondu aux quelques questions pos\u00e9es par la Cour.<\/p>\n\n\n\n

Enfin, le pr\u00e9sident de la Cour a cl\u00f4tur\u00e9 cette audience historique en indiquant que l’action principale en r\u00e9vocation et la demande reconventionnelle en r\u00e9vocation \u00e9tant toujours deux proc\u00e9dures distinctes, ce n’est pas une mais deux d\u00e9cisions qui seront rendues prochainement. <\/p>\n\n\n\n

Il va sans dire que la tenue de l’audience dans le d\u00e9lai plus que respect\u00e9 d’un an de la JUB remplit sa promesse de traiter rapidement des litiges tr\u00e8s sophistiqu\u00e9s en mati\u00e8re de brevets : une v\u00e9ritable r\u00e9ussite pour l’Europe et le droit europ\u00e9en des brevets !<\/p>\n","protected":false},"excerpt":{"rendered":"

La Juridiction unifi\u00e9e du brevet (“JUB”) a gagn\u00e9 son pari ! Le 7 juin 2024, et seulement dix mois apr\u00e8s la signification de l’action en r\u00e9vocation en ao\u00fbt 2023, la premi\u00e8re audience sur le fond devant la Division Centrale de Paris (“PCD”) de la JUB s’est historiquement d\u00e9roul\u00e9e dans le cadre de l’action en nullit\u00e9 […]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-1374","post","type-post","status-publish","format-standard","hentry","category-communiques"],"acf":[],"yoast_head":"\nGide x Regimbeau \u2013 Patent litigation : premi\u00e8re audience historique sur le fond devant la division centrale de Paris de la JUB dans l'affaire Meril Italy S.r.l. contre Edwards Lifesciences Corporation - Gide X Regimbeau<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gide x Regimbeau \u2013 Patent litigation : premi\u00e8re audience historique sur le fond devant la division centrale de Paris de la JUB dans l'affaire Meril Italy S.r.l. contre Edwards Lifesciences Corporation - Gide X Regimbeau\" \/>\n<meta property=\"og:description\" content=\"La Juridiction unifi\u00e9e du brevet (“JUB”) a gagn\u00e9 son pari ! Le 7 juin 2024, et seulement dix mois apr\u00e8s la signification de l’action en r\u00e9vocation en ao\u00fbt 2023, la premi\u00e8re audience sur le fond devant la Division Centrale de Paris (“PCD”) de la JUB s’est historiquement d\u00e9roul\u00e9e dans le cadre de l’action en nullit\u00e9 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/\" \/>\n<meta property=\"og:site_name\" content=\"Gide X Regimbeau\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-12T09:12:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-12T09:20:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.gide-regimbeau-patentlitigation.com\/wp-content\/uploads\/2024\/06\/Gide-x-Regimbeau-1-1024x696.png\" \/>\n<meta name=\"author\" content=\"Gide x Regimbeau\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gide x Regimbeau\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/\"},\"author\":{\"name\":\"Gide x Regimbeau\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/#\\\/schema\\\/person\\\/f4e32bdaa870b360d16fd75ae85f2f1d\"},\"headline\":\"Gide x Regimbeau \u2013 Patent litigation : premi\u00e8re audience historique sur le fond devant la division centrale de Paris de la JUB dans l’affaire Meril Italy S.r.l. contre Edwards Lifesciences Corporation\",\"datePublished\":\"2024-06-12T09:12:13+00:00\",\"dateModified\":\"2024-06-12T09:20:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/\"},\"wordCount\":752,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Gide-x-Regimbeau-1-1024x696.png\",\"articleSection\":[\"Communiqu\u00e9s\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/\",\"url\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/\",\"name\":\"Gide x Regimbeau \u2013 Patent litigation : premi\u00e8re audience historique sur le fond devant la division centrale de Paris de la JUB dans l'affaire Meril Italy S.r.l. contre Edwards Lifesciences Corporation - Gide X Regimbeau\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Gide-x-Regimbeau-1-1024x696.png\",\"datePublished\":\"2024-06-12T09:12:13+00:00\",\"dateModified\":\"2024-06-12T09:20:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/#\\\/schema\\\/person\\\/f4e32bdaa870b360d16fd75ae85f2f1d\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Gide-x-Regimbeau-1-1024x696.png\",\"contentUrl\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Gide-x-Regimbeau-1-1024x696.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gide x Regimbeau \u2013 Patent litigation : premi\u00e8re audience historique sur le fond devant la division centrale de Paris de la JUB dans l’affaire Meril Italy S.r.l. contre Edwards Lifesciences Corporation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/#website\",\"url\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/\",\"name\":\"Gide X Regimbeau\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/#\\\/schema\\\/person\\\/f4e32bdaa870b360d16fd75ae85f2f1d\",\"name\":\"Gide x Regimbeau\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be57961f463a0633bf393525c8925b61935ff71e0f63c5efb92e0e5ce18e9c95?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be57961f463a0633bf393525c8925b61935ff71e0f63c5efb92e0e5ce18e9c95?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be57961f463a0633bf393525c8925b61935ff71e0f63c5efb92e0e5ce18e9c95?s=96&d=mm&r=g\",\"caption\":\"Gide x Regimbeau\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gide x Regimbeau \u2013 Patent litigation : premi\u00e8re audience historique sur le fond devant la division centrale de Paris de la JUB dans l'affaire Meril Italy S.r.l. contre Edwards Lifesciences Corporation - Gide X Regimbeau","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/","og_locale":"fr_FR","og_type":"article","og_title":"Gide x Regimbeau \u2013 Patent litigation : premi\u00e8re audience historique sur le fond devant la division centrale de Paris de la JUB dans l'affaire Meril Italy S.r.l. contre Edwards Lifesciences Corporation - Gide X Regimbeau","og_description":"La Juridiction unifi\u00e9e du brevet (“JUB”) a gagn\u00e9 son pari ! Le 7 juin 2024, et seulement dix mois apr\u00e8s la signification de l’action en r\u00e9vocation en ao\u00fbt 2023, la premi\u00e8re audience sur le fond devant la Division Centrale de Paris (“PCD”) de la JUB s’est historiquement d\u00e9roul\u00e9e dans le cadre de l’action en nullit\u00e9 […]","og_url":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/","og_site_name":"Gide X Regimbeau","article_published_time":"2024-06-12T09:12:13+00:00","article_modified_time":"2024-06-12T09:20:10+00:00","og_image":[{"url":"https:\/\/www.gide-regimbeau-patentlitigation.com\/wp-content\/uploads\/2024\/06\/Gide-x-Regimbeau-1-1024x696.png","type":"","width":"","height":""}],"author":"Gide x Regimbeau","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Gide x Regimbeau","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/#article","isPartOf":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/"},"author":{"name":"Gide x Regimbeau","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/#\/schema\/person\/f4e32bdaa870b360d16fd75ae85f2f1d"},"headline":"Gide x Regimbeau \u2013 Patent litigation : premi\u00e8re audience historique sur le fond devant la division centrale de Paris de la JUB dans l’affaire Meril Italy S.r.l. contre Edwards Lifesciences Corporation","datePublished":"2024-06-12T09:12:13+00:00","dateModified":"2024-06-12T09:20:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/"},"wordCount":752,"commentCount":0,"image":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gide-regimbeau-patentlitigation.com\/wp-content\/uploads\/2024\/06\/Gide-x-Regimbeau-1-1024x696.png","articleSection":["Communiqu\u00e9s"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/","url":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/","name":"Gide x Regimbeau \u2013 Patent litigation : premi\u00e8re audience historique sur le fond devant la division centrale de Paris de la JUB dans l'affaire Meril Italy S.r.l. contre Edwards Lifesciences Corporation - Gide X Regimbeau","isPartOf":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/#primaryimage"},"image":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gide-regimbeau-patentlitigation.com\/wp-content\/uploads\/2024\/06\/Gide-x-Regimbeau-1-1024x696.png","datePublished":"2024-06-12T09:12:13+00:00","dateModified":"2024-06-12T09:20:10+00:00","author":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/#\/schema\/person\/f4e32bdaa870b360d16fd75ae85f2f1d"},"breadcrumb":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/#primaryimage","url":"https:\/\/www.gide-regimbeau-patentlitigation.com\/wp-content\/uploads\/2024\/06\/Gide-x-Regimbeau-1-1024x696.png","contentUrl":"https:\/\/www.gide-regimbeau-patentlitigation.com\/wp-content\/uploads\/2024\/06\/Gide-x-Regimbeau-1-1024x696.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-premiere-audience-historique-sur-le-fond-devant-la-division-centrale-de-paris-de-la-jub-dans-laffaire-meril-italy-s-r-l-contre-edwards-lifesciences-co\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Gide x Regimbeau \u2013 Patent litigation : premi\u00e8re audience historique sur le fond devant la division centrale de Paris de la JUB dans l’affaire Meril Italy S.r.l. contre Edwards Lifesciences Corporation"}]},{"@type":"WebSite","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/#website","url":"https:\/\/www.gide-regimbeau-patentlitigation.com\/","name":"Gide X Regimbeau","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gide-regimbeau-patentlitigation.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/#\/schema\/person\/f4e32bdaa870b360d16fd75ae85f2f1d","name":"Gide x Regimbeau","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/be57961f463a0633bf393525c8925b61935ff71e0f63c5efb92e0e5ce18e9c95?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/be57961f463a0633bf393525c8925b61935ff71e0f63c5efb92e0e5ce18e9c95?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/be57961f463a0633bf393525c8925b61935ff71e0f63c5efb92e0e5ce18e9c95?s=96&d=mm&r=g","caption":"Gide x Regimbeau"}}]}},"_links":{"self":[{"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/posts\/1374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/comments?post=1374"}],"version-history":[{"count":1,"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/posts\/1374\/revisions"}],"predecessor-version":[{"id":1377,"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/posts\/1374\/revisions\/1377"}],"wp:attachment":[{"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/media?parent=1374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/categories?post=1374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/tags?post=1374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}